BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 16715122)

  • 21. Development of trans-2-[1H-imidazol-4-yl] cyclopropane derivatives as new high-affinity histamine H3 receptor ligands.
    Tedford CE; Phillips JG; Gregory R; Pawlowski GP; Fadnis L; Khan MA; Ali SM; Handley MK; Yates SL
    J Pharmacol Exp Ther; 1999 May; 289(2):1160-8. PubMed ID: 10215700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effect of sodium ions and guanine nucleotides on the binding of thioperamide and clobenpropit to histamine H3-receptors in rat cerebral cortical membranes.
    Clark EA; Hill SJ
    Br J Pharmacol; 1995 Jan; 114(2):357-62. PubMed ID: 7881735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterisation of the specific binding of the histamine H3 receptor antagonist radioligand [3H]GR168320.
    Brown JD; O'Shaughnessy CT; Kilpatrick GJ; Scopes DI; Beswick P; Clitherow JW; Barnes JC
    Eur J Pharmacol; 1996 Sep; 311(2-3):305-10. PubMed ID: 8891613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imidazole H3-antagonists: relationship between structure and ex vivo binding to rat brain H3-receptors.
    Vacondio F; Mor M; Silva C; Zuliani V; Rivara M; Rivara S; Bordi F; Plazzi PV; Magnanini F; Bertoni S; Ballabeni V; Barocelli E; Carrupt PA; Testa B
    Eur J Pharm Sci; 2004 Sep; 23(1):89-98. PubMed ID: 15324926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histamine homologues discriminating between two functional H3 receptor assays. Evidence for H3 receptor heterogeneity?
    Leurs R; Kathmann M; Vollinga RC; Menge WM; Schlicker E; Timmerman H
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1009-15. PubMed ID: 8786529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constitutive activity of histamine h(3) receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H(3) antagonists.
    Wieland K; Bongers G; Yamamoto Y; Hashimoto T; Yamatodani A; Menge WM; Timmerman H; Lovenberg TW; Leurs R
    J Pharmacol Exp Ther; 2001 Dec; 299(3):908-14. PubMed ID: 11714875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The human histamine H3 receptor couples to GIRK channels in Xenopus oocytes.
    Sahlholm K; Nilsson J; Marcellino D; Fuxe K; Arhem P
    Eur J Pharmacol; 2007 Jul; 567(3):206-10. PubMed ID: 17537431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the binding of the first selective radiolabelled histamine H3-receptor antagonist, [125I]-iodophenpropit, to rat brain.
    Jansen FP; Wu TS; Voss HP; Steinbusch HW; Vollinga RC; Rademaker B; Bast A; Timmerman H
    Br J Pharmacol; 1994 Oct; 113(2):355-62. PubMed ID: 7834183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steroid-sensitivity of agonist binding to pituitary cell line histamine H3 receptors.
    West RE; Myers J; Zweig A; Siegel MI; Egan RW; Clark MA
    Eur J Pharmacol; 1994 May; 267(3):343-8. PubMed ID: 8088374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons.
    Dai H; Fu Q; Shen Y; Hu W; Zhang Z; Timmerman H; Leurs R; Chen Z
    Eur J Pharmacol; 2007 Jun; 563(1-3):117-23. PubMed ID: 17350613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of histamine H3 receptors in mouse brain using the H3 antagonist [125I]iodophenpropit.
    Jansen FP; Mochizuki T; Maeyama K; Leurs R; Timmerman H
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jul; 362(1):60-7. PubMed ID: 10935534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of histamine H3 receptor agonist-stimulated [35S]GTP gamma[S] binding to pertussis toxin.
    Clark EA; Hill SJ
    Eur J Pharmacol; 1996 Jan; 296(2):223-5. PubMed ID: 8838460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.
    Yates SL; Phillips JG; Gregory R; Pawlowski GP; Fadnis L; Khan MA; Ali SM; Tedford CE
    J Pharmacol Exp Ther; 1999 May; 289(2):1151-9. PubMed ID: 10215699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective histamine H₃ and H₄ receptor agonists exert opposite effects against the gastric lesions induced by HCl in the rat stomach.
    Coruzzi G; Adami M; Pozzoli C; de Esch IJ; Smits R; Leurs R
    Eur J Pharmacol; 2011 Nov; 669(1-3):121-7. PubMed ID: 21839070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding characteristics of a histamine H3-receptor antagonist, [3H]S-methylthioperamide: comparison with [3H](R)alpha-methylhistamine binding to rat tissues.
    Yanai K; Ryu JH; Sakai N; Takahashi T; Iwata R; Ido T; Murakami K; Watanabe T
    Jpn J Pharmacol; 1994 Jun; 65(2):107-12. PubMed ID: 7967223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of cell lines for drug discovery through random activation of gene expression: application to the human histamine H3 receptor.
    Song J; Doucette C; Hanniford D; Hunady K; Wang N; Sherf B; Harrington JJ; Brunden KR; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Jun; 3(3):309-18. PubMed ID: 15971992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.
    Ligneau X; Lin J; Vanni-Mercier G; Jouvet M; Muir JL; Ganellin CR; Stark H; Elz S; Schunack W; Schwartz J
    J Pharmacol Exp Ther; 1998 Nov; 287(2):658-66. PubMed ID: 9808693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
    Garbarg M; Arrang JM; Rouleau A; Ligneau X; Tuong MD; Schwartz JC; Ganellin CR
    J Pharmacol Exp Ther; 1992 Oct; 263(1):304-10. PubMed ID: 1383495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ligands of the histamine H3-receptor: new potent antagonists of the 2-thioimidazole type.
    Plazzi PV; Mor M; Bordi F; Silva C; Rivara S; Caretta A; Ballabeni V; Impicciatore M; Vitali T
    Farmaco; 1997 May; 52(5):295-302. PubMed ID: 9274000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.
    Ishikawa M; Watanabe T; Kudo T; Yokoyama F; Yamauchi M; Kato K; Kakui N; Sato Y
    J Med Chem; 2010 Sep; 53(17):6445-56. PubMed ID: 20690643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.